Who are Naloxone Hydrochloride's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/naloxone-hydrochloride.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Naloxone Hydrochloride — Competitive Intelligence Brief

Naloxone Hydrochloride (Naloxone Hydrochloride) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Mixed opioid agonist-antagonist with opioid antagonist. Area: Pain.

marketed Mixed opioid agonist-antagonist with opioid antagonist Opioid receptors (mu, kappa) Pain Small molecule Live · refreshed every 30 min

Target snapshot

Naloxone Hydrochloride (Naloxone Hydrochloride) — Pfizer Inc.. Pentazocine is a mixed agonist-antagonist at opioid receptors; naloxone is an opioid antagonist.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Naloxone Hydrochloride TARGET	Naloxone Hydrochloride	Pfizer Inc.	marketed	Mixed opioid agonist-antagonist with opioid antagonist	Opioid receptors (mu, kappa)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2026-06-01 — Naloxone Hydrochloride · 7731686 · Formulation · US
2026-06-25 — Naloxone Hydrochloride · 10960155 · Formulation · US
2026-12-12 — Naloxone Hydrochloride · 11590286 · Formulation · US
2027-02-20 — Naloxone Hydrochloride · 9238108 · Formulation · US
2027-02-27 — Naloxone Hydrochloride · 8206360 · Formulation · US
2027-05-23 — Naloxone Hydrochloride · 9724471 · Formulation · US
2028-03-12 — Naloxone Hydrochloride · 7947017 · Formulation · US
2028-10-30 — Naloxone Hydrochloride · 7749194 · Formulation · US
2028-11-25 — Naloxone Hydrochloride · 8231573 · Formulation · US
2029-04-10 — Naloxone Hydrochloride · 8226610 · Formulation · US
2029-11-02 — Naloxone Hydrochloride · 8021344 · Formulation · US
2031-02-28 — Naloxone Hydrochloride · 9814838 · Formulation · US
2031-02-28 — Naloxone Hydrochloride · 8939943 · Formulation · US
2031-02-28 — Naloxone Hydrochloride · 9022022 · Formulation · US
2031-02-28 — Naloxone Hydrochloride · 10322239 · Method of Use · US
2031-02-28 — Naloxone Hydrochloride · 9474869 · Formulation · US
2031-05-24 — Naloxone Hydrochloride · 10143792 · Method of Use · US
2031-05-24 — Naloxone Hydrochloride · 10143972 · Method of Use · US
2032-02-04 — Naloxone Hydrochloride · 8627816 · Formulation · US
2032-05-11 — Naloxone Hydrochloride · 12458591 · Method of Use · US
2032-05-11 — Naloxone Hydrochloride · 11806428 · Formulation · US
2032-05-11 — Naloxone Hydrochloride · 11020343 · Method of Use · US
2034-07-18 — Naloxone Hydrochloride · 9517307 · Formulation · US
2034-08-26 — Naloxone Hydrochloride · 11135155 · Formulation · US
2034-08-26 — Naloxone Hydrochloride · 11617713 · Formulation · US
2034-08-26 — Naloxone Hydrochloride · 11628139 · Formulation · US
2034-08-26 — Naloxone Hydrochloride · 10973814 · Formulation · US
2034-08-26 — Naloxone Hydrochloride · 10722510 · Formulation · US
2034-08-26 — Naloxone Hydrochloride · 11975096 · Formulation · US
2034-08-26 — Naloxone Hydrochloride · 12414915 · Formulation · US

Sponsor landscape (Mixed opioid agonist-antagonist with opioid antagonist class)

Pfizer Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Naloxone Hydrochloride — Competitive Intelligence Brief. https://druglandscape.com/ci/naloxone-hydrochloride. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab